• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾动脉狭窄所致氮质血症:经皮血管成形术治疗

Azotemia caused by renal artery stenosis: treatment by percutaneous angioplasty.

作者信息

Martin L G, Casarella W J, Gaylord G M

机构信息

Department of Radiology, Emory University Hospital, Atlanta, GA 30322.

出版信息

AJR Am J Roentgenol. 1988 Apr;150(4):839-44. doi: 10.2214/ajr.150.4.839.

DOI:10.2214/ajr.150.4.839
PMID:2964774
Abstract

Percutaneous angioplasty of the renal artery was performed in 79 patients who had stable or climbing serum creatinine levels greater than 1.7 mg/dl and hemodynamically significant stenosis of the renal artery. Patients who had nonrenal causes of azotemia, nephropathy caused by iodinated contrast material, or serum creatinine levels that were declining while the patients were receiving medical therapy before angioplasty were excluded from the study. Angioplasty resulted in a significant (greater than 20%) decline in the level of serum creatinine (average, 2.7 mg/dl before to 1.7 mg/dl after) in 43% of these patients during an average follow-up period of 16 months. A significant decrease in the level of serum creatinine was seen in 61% of patients with bilateral stenosis, 38% of patients with unilateral stenosis with absent contralateral renal blood flow, and 38% of patients with unilateral stenosis and normal contralateral renal blood flow. Recapture of lost nephron function was least successful in patients whose levels of serum creatinine were greater than 4.0 mg/dl (14%); this included one (11%) of nine patients who were already on hemodialysis. We conclude that angioplasty of the renal artery can play a major role in the treatment of patients who have mild azotemia and bilateral stenosis of the renal artery. It is less successful in treatment of patients who have severe azotemia and those who have unilateral disease.

摘要

对79例血清肌酐水平稳定或持续升高且大于1.7mg/dl、肾动脉存在血流动力学显著狭窄的患者进行了经皮肾动脉血管成形术。排除有非肾性氮质血症病因、碘造影剂所致肾病或在血管成形术前接受药物治疗时血清肌酐水平下降的患者。在平均16个月的随访期内,43%的此类患者血管成形术后血清肌酐水平显著下降(超过20%)(平均从术前的2.7mg/dl降至术后的1.7mg/dl)。双侧狭窄患者中61%、单侧狭窄且对侧肾血流缺失患者中38%以及单侧狭窄且对侧肾血流正常患者中38%的血清肌酐水平显著下降。血清肌酐水平大于4.0mg/dl的患者恢复丢失的肾单位功能最不成功(14%);这包括9例已接受血液透析患者中的1例(11%)。我们得出结论,肾动脉血管成形术在治疗轻度氮质血症和双侧肾动脉狭窄患者中可发挥主要作用。在治疗重度氮质血症患者和单侧病变患者中效果较差。

相似文献

1
Azotemia caused by renal artery stenosis: treatment by percutaneous angioplasty.肾动脉狭窄所致氮质血症:经皮血管成形术治疗
AJR Am J Roentgenol. 1988 Apr;150(4):839-44. doi: 10.2214/ajr.150.4.839.
2
Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis.严重动脉粥样硬化性肾动脉开口狭窄经皮支架辅助血管成形术后肾功能改善的预测因素。
Circulation. 2003 Nov 4;108(18):2244-9. doi: 10.1161/01.CIR.0000095786.44712.2A. Epub 2003 Oct 13.
3
A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.一项关于肾衰竭患者经皮腔内肾血管成形术疗效的研究。
Nephron Clin Pract. 2006;104(3):c132-42. doi: 10.1159/000094916. Epub 2006 Aug 7.
4
Transluminal angioplasty in patients with bilateral renal artery stenosis or renal artery stenosis in a solitary functioning kidney.双侧肾动脉狭窄或单肾功能肾动脉狭窄患者的腔内血管成形术。
AJR Am J Roentgenol. 1989 Dec;153(6):1305-8. doi: 10.2214/ajr.153.6.1305.
5
[Pattern of blood creatinine levels in 140 hypertensive patients after successful percutaneous transluminal angioplasty for renal artery stenosis].[140例肾动脉狭窄患者经皮腔内血管成形术成功后血肌酐水平变化模式]
J Radiol. 1993 Dec;74(12):609-13.
6
[Evolution of serum creatinine level 48 hours after angioplasty for renal artery stenosis in 91 patients].[91例肾动脉狭窄血管成形术后48小时血清肌酐水平的变化]
Ann Radiol (Paris). 1995;38(7-8):447-50.
7
Does percutaneous transluminal renal artery angioplasty improve blood pressure control and renal function in patients with atherosclerotic renal artery stenosis?经皮腔内肾动脉血管成形术能否改善动脉粥样硬化性肾动脉狭窄患者的血压控制和肾功能?
Isr Med Assoc J. 2011 Oct;13(10):619-24.
8
Captopril therapy following percutaneous transluminal angioplasty for bilateral renal artery stenosis.经皮腔内血管成形术治疗双侧肾动脉狭窄后的卡托普利治疗
Arch Intern Med. 1989 Sep;149(9):1973-6.
9
Percutaneous transluminal renal angioplasty and renal function.
Radiologe. 1989 Apr;29(4):195-200.
10
Diabetes mellitus does not preclude stabilization or improvement of renal function after stent revascularization in patients with kidney insufficiency and renal artery stenosis.糖尿病并不妨碍肾功能不全和肾动脉狭窄患者在支架血管重建术后肾功能的稳定或改善。
Catheter Cardiovasc Interv. 2007 May 1;69(6):902-7. doi: 10.1002/ccd.20980.

引用本文的文献

1
Management of atherosclerotic renovascular disease: the effect of renal artery stenting on renal function and blood pressure.
Int Urol Nephrol. 2006;38(3-4):683-91. doi: 10.1007/s11255-006-9025-5.
2
The diagnosis and management of renovascular disease: a primary care perspective. Part II. Issues in management.肾血管疾病的诊断与管理:初级保健视角。第二部分。管理中的问题。
J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4):261-8. doi: 10.1111/j.1524-6175.2003.01811.x.
3
Atherosclerotic renal artery stenosis: from diagnosis to treatment.动脉粥样硬化性肾动脉狭窄:从诊断到治疗
Postgrad Med J. 1999 Sep;75(887):527-36. doi: 10.1136/pgmj.75.887.527.
4
Stent revascularization for atherosclerotic renal artery stenosis. 1-year clinical follow-up.动脉粥样硬化性肾动脉狭窄的支架血管重建术。1年临床随访。
Tex Heart Inst J. 1998;25(1):40-3.
5
Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patients.
Cardiovasc Intervent Radiol. 1994 May-Jun;17(3):143-6. doi: 10.1007/BF00195507.
6
Percutaneous recanalization of recent renal artery occlusions: report of 10 cases.
Cardiovasc Intervent Radiol. 1994 Sep-Oct;17(5):258-63. doi: 10.1007/BF00192448.
7
Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series.经皮腔内血管成形术治疗肾血管性高血压的血压反应:已发表系列研究综述
BMJ. 1990 Mar 3;300(6724):569-72. doi: 10.1136/bmj.300.6724.569.